Sophia Athanasiou

Sophia Athanasiou is a seasoned healthcare professional specializing in Drug Safety Operations, with a proven track record of implementing global systems and process initiatives to enhance efficiency and compliance. With extensive experience in various leadership roles, including Vice President of Patient Safety Risk Management at Relay Therapeutics and prior positions such as Director of Safety & Pharmacovigilance at Immunomedics and Head of US Drug Safety at DBV Technologies, Sophia brings valuable expertise to the field. Educational qualifications include a Bachelor of Science in Pharmacy and a Bachelor of Science in Biology, both from Rutgers University.